Webcasting - The Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

The 1^st Asia Pacific Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Shanghai, China, June 2-5, 2011

Webcasting

Selected Presentations from the Congress Scientific Program.

Friday, June 3, 2011

	Inflammation and anti inflammatory drugs to treat diabetes Prof. V.A. Fonseca, USA

	Genetics of T2D in the Chinese population Prof. L. Ji, China

	Recent trial to prevent CV disease: Is this the answer or has it created more questions? Prof. J. Chan, China-HK

	The role of Beta cell insulin resistance: Worldwide vs. China Prof. R.A. DeFronzo, USA

	First line therapy: Glucosidase INH and Sulfonylurea Prof. M. Hanefeld, Germany

	Should we avoid antihypertensive drugs that increase glucose levels? Prof. E. Standl, Germany

	Should we change the target blood pressure in diabetic patients? Prof. E. Grossman, Israel

	The role of iron in diabetes and its complications- was iron deficiency protective in Asia and have we lost the protection? Prof. V.A Fonseca, USA

	Do we need anti-obesity drugs? No: lifestyle intervention only Prof. L. Van Gaal, Belgium

	Do we need anti-obesity drugs? YES Prof. V. Hainer, Czech Republic

Saturday, June 4, 2011

	Should we aim to normalise A1c? Con Prof. K. Abdul Kadir, Malaysia

	Early in the obese patient with risk factors Pro Prof. S.K.H. Wong, China- HK

	Early in the obese patient with risk factors Con Prof. W.H-H. Sheu, Taiwan

Sunday, June 5, 2011

	Prevention of T2DM: Call for early intervention Prof. R.A. DeFronzo, USA

	Diabetes and Cancer Prof. X. Yang, China- HK

	Insulin and Cancer Prof. P. Home, UK

	Combination of GLP-1 analog and long acting insulin as third line therapy for T2D Prof. G. Schernthaner, Austria